Andreas Schröder

3.3k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Andreas Schröder is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Andreas Schröder has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Andreas Schröder's work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Andreas Schröder is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Andreas Schröder collaborates with scholars based in Germany, United States and Switzerland. Andreas Schröder's co-authors include Christian Weber, Georg Ostermann, Alma Zernecke, Kim S. C. Weber, Paul B. Rothman, Tobias Weber, Nina Gellert, Jiřı́ Neužil, Stephen M. Canfield and Robert J. Coffey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Andreas Schröder

32 papers receiving 1.7k citations

Hit Papers

JAM-1 is a ligand of the β2 integrin LFA-1 involved in tr... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes
    2002 515 citations Georg Ostermann, Kim S. C. Weber et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Schröder Germany 18 784 609 342 273 206 32 1.7k
Marsha Penman United States 19 1.4k 1.8× 1.2k 1.9× 194 0.6× 504 1.8× 276 1.3× 23 3.6k
Gerald Ranges United States 23 785 1.0× 1.4k 2.3× 336 1.0× 554 2.0× 70 0.3× 37 2.7k
Hervé Benoist France 21 846 1.1× 579 1.0× 86 0.3× 152 0.6× 121 0.6× 83 1.7k
Édith Beaulieu Canada 21 529 0.7× 165 0.3× 125 0.4× 578 2.1× 76 0.4× 35 1.6k
Hai Le Trong United States 16 1.3k 1.6× 655 1.1× 298 0.9× 287 1.1× 36 0.2× 18 2.3k
Kyra A. Gelderman Netherlands 23 621 0.8× 1.4k 2.3× 95 0.3× 242 0.9× 38 0.2× 57 2.2k
Mark M. Zukowski United States 17 1.3k 1.7× 882 1.4× 430 1.3× 272 1.0× 17 0.1× 19 2.5k
Rebecca Chinery United Kingdom 25 1.4k 1.8× 626 1.0× 56 0.2× 491 1.8× 72 0.3× 39 2.8k
Bassam B. Damaj United States 19 553 0.7× 665 1.1× 107 0.3× 322 1.2× 61 0.3× 30 1.4k
Natalie J. Avdi United States 15 890 1.1× 1.2k 1.9× 371 1.1× 276 1.0× 17 0.1× 16 2.1k

Countries citing papers authored by Andreas Schröder

Since Specialization
Citations

This map shows the geographic impact of Andreas Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schröder more than expected).

Fields of papers citing papers by Andreas Schröder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schröder. The network helps show where Andreas Schröder may publish in the future.

Co-authorship network of co-authors of Andreas Schröder

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schröder. A scholar is included among the top collaborators of Andreas Schröder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schröder. Andreas Schröder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bossi, Paolo, Naomi Kiyota, Ricard Mesı́a, et al.. (2025). Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review. Oral Oncology. 169. 107596–107596. 1 indexed citations
2.
Bourhis, Jean, Lisa Licitra, Barbara Burtness, et al.. (2025). Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study. Journal of Clinical Oncology. 43(29). 3209–3220. 2 indexed citations
3.
Schröder, Andreas, et al.. (2024). Identification of anti-inflammatory and anti-cancer compounds targeting the NF-κB-NLRP3 inflammasome pathway from a phytochemical library of the Sideritis genus. Journal of Ethnopharmacology. 338(Pt 2). 119074–119074. 1 indexed citations
4.
Weber, Christian, Tilman Schultze, Stephan Göttig, et al.. (2022). Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital. Microbiology Spectrum. 10(5). e0169722–e0169722. 15 indexed citations
5.
Stenzl, Arnulf, Isabel Syndikus, Tomasz Sarosiek, et al.. (2017). Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 28. v408–v409. 32 indexed citations
6.
Hong, Henoch S., Sven D. Koch, Birgit Scheel, et al.. (2016). Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. OncoImmunology. 5(12). e1249560–e1249560. 18 indexed citations
7.
Rossmann, Eva, Anders Österborg, Eva Löfvenberg, et al.. (2014). Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study. Human Vaccines & Immunotherapeutics. 10(11). 3394–3408. 18 indexed citations
8.
Rossmann, Eva, Anders Österborg, Eva Löfvenberg, et al.. (2011). Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma. Blood. 118(21). 2927–2927. 1 indexed citations
9.
Wabnitz, Guido, Gabriele Nebl, Martin Klemke, Andreas Schröder, & Yvonne Samstag. (2006). Phosphatidylinositol 3-Kinase Functions as a Ras Effector in the Signaling Cascade That Regulates Dephosphorylation of the Actin-Remodeling Protein Cofilin after Costimulation of Untransformed Human T Lymphocytes. The Journal of Immunology. 176(3). 1668–1674. 48 indexed citations
10.
Schröder, Andreas, et al.. (2006). Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes. Medical Microbiology and Immunology. 195(4). 185–194. 68 indexed citations
11.
Köster, Frank, Andreas Schröder, D. Finas, et al.. (2006). Cell-specific enhancement of liposomal transfection by steroids in steroid receptor expressing cells. International Journal of Molecular Medicine. 18(6). 1201–5. 7 indexed citations
12.
Canfield, Stephen M., Youngnam Lee, Andreas Schröder, & Paul B. Rothman. (2005). Cutting Edge: IL-4 Induces Suppressor of Cytokine Signaling-3 Expression in B Cells by a Mechanism Dependent on Activation of p38 MAPK. The Journal of Immunology. 174(5). 2494–2498. 54 indexed citations
13.
Arimura, Akinori, et al.. (2004). The Transcriptional Co-activator p/CIP (NCoA-3) Is Up-regulated by STAT6 and Serves as a Positive Regulator of Transcriptional Activation by STAT6. Journal of Biological Chemistry. 279(30). 31105–31112. 47 indexed citations
14.
Hanke, P, Wolfgang Jagla, Sigrid Wattler, et al.. (2004). Synergistic interaction of two independent genetic loci causes extreme elevation of serum IgA in mice. Genes and Immunity. 5(5). 375–380. 6 indexed citations
15.
Schröder, Andreas, et al.. (2002). Cutting Edge: STAT6 Serves as a Positive and Negative Regulator of Gene Expression in IL-4-Stimulated B Lymphocytes. The Journal of Immunology. 168(3). 996–1000. 78 indexed citations
16.
Weber, Tobias, Min Lu, Ladislav Anděra, et al.. (2002). Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.. PubMed. 8(3). 863–9. 164 indexed citations
17.
Ostermann, Georg, Kim S. C. Weber, Alma Zernecke, Andreas Schröder, & Christian Weber. (2002). JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunology. 3(2). 151–158. 515 indexed citations breakdown →
18.
Schröder, Andreas, et al.. (2002). Untersuchungen zur Expression von Proteintyrosinkinasen der FAK- (Focal Adhesion Kinase-)Familie in Osteosarkomen. Der Pathologe. 23(5). 361–366. 8 indexed citations
19.
20.
Schröder, Andreas, Roman A. Blaheta, Martin Scholz, et al.. (1995). EFFECTS OF PROINFLAMMATORY CYTOKINES ON CULTIVATED PRIMARY HUMAN HEPATOCYTES. Transplantation. 59(7). 1023–1028. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marsha Penman Breakdown of academic impact, for papers by Gerald Ranges Breakdown of academic impact, for papers by Hervé Benoist Breakdown of academic impact, for papers by Édith Beaulieu Breakdown of academic impact, for papers by Hai Le Trong Breakdown of academic impact, for papers by Kyra A. Gelderman Breakdown of academic impact, for papers by Mark M. Zukowski Breakdown of academic impact, for papers by Rebecca Chinery Breakdown of academic impact, for papers by Bassam B. Damaj Breakdown of academic impact, for papers by Natalie J. Avdi
Rankless by CCL
2026